Several amendments to pharmaceutical promotional laws in Hungary came into effect on 1 January 2025, with others following on 1 February 2025. Some of these amendments have long been urged by the pharmaceutical industry.
TGS Baltic, Ristal Keba Partners, and Sirel & Partners Advise on IVC Evidensia's Acquisition of Tartu Loomakliinik
TGS Baltic has advised IVC Evidensia on its acquisition of Tartu Loomakliinik. Ristal Keba Partners and Sirel & Partners advised the sellers, Karerin OU and Kersti Paju.
NKO Partners Advises Dr Max on Acquisition of VIVA Pharm
NKO Partners has advised Dr Max on its acquisition of VIVA Pharm pharmacy chain.
BDK Advokati and Mikijelj, Jankovic & Bogdanovic Advise on Vetti Group's Acquisition of Vet Planet Clinic
BDK Advokati has advised Vetti Group on its acquisition of 80% of Belgrade-based animal healthcare institution Vet Planet Clinic from Andrija Dakovic. Mikijelj, Jankovic & Bogdanovic advised the seller.
White & Case Advises on CZK 1.25 Billion Retail Bond Issuance by Dr. Max
White & Case has advised on Dr. Max’s second retail domestic bond issuance valued at CZK 1.25 billion, guaranteed by Glebi Holdings, and listed on the Prague Stock Exchange.
Stratulat Albulescu Advises Duman Clinic on EUR 1.06 Million Acquisition of La Stejari
Stratulat Albulescu has advised Duman Clinic on the acquisition of La Stejari, which owns and operates a hotel in Pianu de Jos, Alba County, from sellers Dorin Mateiu and Ioan Strajan.
CMS and Bird & Bird Advise on Egis' Acquisition of Dermatological Product Line from Teva
CMS has advised Egis Pharmaceuticals on its acquisition of a dermatological product line from Teva Pharmaceutical Industries. Bird & Bird reportedly Teva.